Arca Biopharma | ABIO - مصروفات التشغيل





مصروفات التشغيل تغيير تاريخ
Alterity Therapeutics Limited AUD 8.67M 893.38K 2025-12
Amgen USD 11.69B 6.9B 2026-06
Arca Biopharma USD 36.43M 2M 2026-03
Biogen USD 2.98B 1.02B 2026-06
Brainstorm Cell Therapeutics USD 2.05M 198K 2026-03
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Capricor Therapeutics USD 29.16M 2.87M 2025-12
Cipla INR 62.31B 3.04B 2026-06
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 11.19M 96K 2026-03
CSL USD 5.7B 2.82B 2025-12
Cytokinetics USD 207.8M 7.22M 2026-06
Daiichi Sankyo JPY 489.64B 21.08B 2026-06
Gilead Sciences USD 3.95B 19.57B 2026-06
GlaxoSmithKline GBP 5.8B 468M 2026-06
Grifols EUR 1.99B 217.4M 2025-12
Laboratory Of America USD 3.27B 146.9M 2026-06
Myriad Genetics USD 212.8M 16.2M 2025-12
Otsuka Holdings JPY 561.64B 49.51B 2026-06
Pfizer USD 85.19B 4.91B 2026-06
United Therapeutics USD 6.4B 499.2M 2026-06